Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

By D’Alessandro R.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Tumour marker CA15-3: possible uses in the routine management of breast cancer

By Tomlinson I.P.M.   Whyman A.   Barrett J.A.   Kremer J.K.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 899-902

Elsevier

Access to resources Recommend Favorite

Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer

By          

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 940-944

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

By Wu Shih-Chung  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 879-882

Springer Publishing Company

Access to resources Recommend Favorite

Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers

By Lee Jun   Park Seho   Park Ji   Cho Jung   Kim Seung   Park Byeong-Woo  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 477-484

Springer Publishing Company

Access to resources Recommend Favorite